Gilead Sciences Stock Current Valuation

GILD Stock  USD 73.01  0.60  0.83%   
Valuation analysis of Gilead Sciences helps investors to measure Gilead Sciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value Multiple is expected to grow to 10.77. Fundamental drivers impacting Gilead Sciences' valuation include:
Price Book
3.9513
Enterprise Value
107.9 B
Enterprise Value Ebitda
10.2841
Price Sales
3.3267
Forward PE
10.2564
Overvalued
Today
73.01
Please note that Gilead Sciences' price fluctuation is very steady at this time. Calculation of the real value of Gilead Sciences is based on 3 months time horizon. Increasing Gilead Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Gilead Sciences is useful when determining the fair value of the Gilead stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Gilead Sciences. Since Gilead Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Gilead Stock. However, Gilead Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  73.01 Real  70.09 Target  85.47 Hype  73.01 Naive  71.46
The real value of Gilead Stock, also known as its intrinsic value, is the underlying worth of Gilead Sciences Company, which is reflected in its stock price. It is based on Gilead Sciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Gilead Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Gilead Sciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
70.09
Real Value
80.31
Upside
Estimating the potential upside or downside of Gilead Sciences helps investors to forecast how Gilead stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Gilead Sciences more accurately as focusing exclusively on Gilead Sciences' fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
1.211.581.97
Details
Hype
Prediction
LowEstimatedHigh
71.2773.0174.75
Details
Potential
Annual Dividend
LowForecastedHigh
1.881.972.07
Details
31 Analysts
Consensus
LowTarget PriceHigh
77.7885.4794.87
Details

Gilead Current Valuation Analysis

Gilead Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
 2021 2022 2023 2024 (projected)
Total Revenue27.3B27.3B27.1B28.5B
Interest Expense1.0B935M944M534.5M

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Gilead Sciences Current Valuation

    
  107.94 B  
Most of Gilead Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gilead Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Gilead Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Gilead Sciences is extremely important. It helps to project a fair market value of Gilead Stock properly, considering its historical fundamentals such as Current Valuation. Since Gilead Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Gilead Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Gilead Sciences' interrelated accounts and indicators.
0.90.950.70.93-0.05-0.12-0.270.990.610.620.730.470.560.530.910.240.87-0.77-0.510.820.690.96-0.250.690.210.730.24-0.58-0.48-0.26
0.90.90.640.87-0.1-0.2-0.530.880.530.420.650.360.470.320.760.270.82-0.64-0.440.750.670.89-0.370.460.340.610.29-0.55-0.48-0.48
0.950.90.540.950.03-0.18-0.360.90.590.520.740.410.460.370.790.410.86-0.65-0.40.720.630.88-0.30.640.180.630.22-0.62-0.39-0.36
0.70.640.540.48-0.27-0.01-0.240.750.190.620.210.350.540.410.64-0.180.74-0.81-0.670.890.740.70.180.580.060.690.3-0.54-0.6-0.28
0.930.870.950.48-0.03-0.27-0.280.90.760.440.770.540.40.470.860.340.74-0.61-0.220.70.480.9-0.490.560.370.520.32-0.46-0.23-0.21
-0.05-0.10.03-0.27-0.030.210.47-0.090.23-0.310.27-0.11-0.260.060.040.44-0.30.40.27-0.46-0.450.02-0.21-0.360.28-0.130.210.430.270.36
-0.12-0.2-0.18-0.01-0.270.210.08-0.09-0.05-0.03-0.12-0.080.02-0.05-0.04-0.17-0.070.0-0.02-0.090.0-0.110.34-0.02-0.22-0.12-0.10.03-0.050.02
-0.27-0.53-0.36-0.24-0.280.470.08-0.230.05-0.11-0.040.08-0.030.35-0.050.04-0.530.20.24-0.44-0.53-0.210.05-0.20.0-0.1-0.070.550.320.9
0.990.880.90.750.9-0.09-0.09-0.230.60.640.710.490.580.580.930.160.85-0.8-0.540.830.70.96-0.230.690.220.750.24-0.55-0.49-0.21
0.610.530.590.190.760.23-0.050.050.60.150.580.750.020.440.750.190.21-0.310.320.34-0.10.69-0.710.110.680.020.460.10.320.21
0.620.420.520.620.44-0.31-0.03-0.110.640.150.170.520.40.210.5-0.050.66-0.9-0.60.630.670.520.270.7-0.450.64-0.42-0.58-0.38-0.19
0.730.650.740.210.770.27-0.12-0.040.710.580.170.120.330.470.790.520.52-0.28-0.280.320.320.76-0.330.330.350.580.22-0.11-0.380.09
0.470.360.410.350.54-0.11-0.080.080.490.750.520.120.060.320.55-0.020.18-0.610.230.440.00.51-0.420.210.280.010.09-0.030.370.17
0.560.470.460.540.4-0.260.02-0.030.580.020.40.330.060.650.470.010.58-0.57-0.670.540.640.490.220.64-0.170.73-0.08-0.46-0.63-0.1
0.530.320.370.410.470.06-0.050.350.580.440.210.470.320.650.650.110.25-0.36-0.250.370.160.58-0.250.460.250.470.290.0-0.180.36
0.910.760.790.640.860.04-0.04-0.050.930.750.50.790.550.470.650.170.65-0.68-0.350.70.470.96-0.290.530.390.640.35-0.24-0.340.08
0.240.270.41-0.180.340.44-0.170.040.160.19-0.050.52-0.020.010.110.170.120.030.0-0.13-0.020.24-0.31-0.02-0.010.21-0.020.05-0.010.03
0.870.820.860.740.74-0.3-0.07-0.530.850.210.660.520.180.580.250.650.12-0.77-0.730.870.930.760.10.81-0.130.790.07-0.86-0.72-0.57
-0.77-0.64-0.65-0.81-0.610.40.00.2-0.8-0.31-0.9-0.28-0.61-0.57-0.36-0.680.03-0.770.6-0.84-0.76-0.72-0.13-0.70.19-0.70.150.60.470.23
-0.51-0.44-0.4-0.67-0.220.27-0.020.24-0.540.32-0.6-0.280.23-0.67-0.25-0.350.0-0.730.6-0.56-0.89-0.42-0.54-0.640.45-0.90.230.620.930.36
0.820.750.720.890.7-0.46-0.09-0.440.830.340.630.320.440.540.370.7-0.130.87-0.84-0.560.80.770.010.750.070.640.31-0.71-0.53-0.41
0.690.670.630.740.48-0.450.0-0.530.7-0.10.670.320.00.640.160.47-0.020.93-0.76-0.890.80.580.350.76-0.340.83-0.13-0.85-0.86-0.6
0.960.890.880.70.90.02-0.11-0.210.960.690.520.760.510.490.580.960.240.76-0.72-0.420.770.58-0.340.570.360.690.34-0.37-0.41-0.12
-0.25-0.37-0.30.18-0.49-0.210.340.05-0.23-0.710.27-0.33-0.420.22-0.25-0.29-0.310.1-0.13-0.540.010.35-0.340.23-0.740.3-0.47-0.22-0.5-0.04
0.690.460.640.580.56-0.36-0.02-0.20.690.110.70.330.210.640.460.53-0.020.81-0.7-0.640.750.760.570.23-0.380.71-0.08-0.76-0.55-0.26
0.210.340.180.060.370.28-0.220.00.220.68-0.450.350.28-0.170.250.39-0.01-0.130.190.450.07-0.340.36-0.74-0.38-0.250.780.380.310.18
0.730.610.630.690.52-0.13-0.12-0.10.750.020.640.580.010.730.470.640.210.79-0.7-0.90.640.830.690.30.71-0.25-0.11-0.53-0.84-0.14
0.240.290.220.30.320.21-0.1-0.070.240.46-0.420.220.09-0.080.290.35-0.020.070.150.230.31-0.130.34-0.47-0.080.78-0.110.090.10.02
-0.58-0.55-0.62-0.54-0.460.430.030.55-0.550.1-0.58-0.11-0.03-0.460.0-0.240.05-0.860.60.62-0.71-0.85-0.37-0.22-0.760.38-0.530.090.590.74
-0.48-0.48-0.39-0.6-0.230.27-0.050.32-0.490.32-0.38-0.380.37-0.63-0.18-0.34-0.01-0.720.470.93-0.53-0.86-0.41-0.5-0.550.31-0.840.10.590.38
-0.26-0.48-0.36-0.28-0.210.360.020.9-0.210.21-0.190.090.17-0.10.360.080.03-0.570.230.36-0.41-0.6-0.12-0.04-0.260.18-0.140.020.740.38
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Gilead Sciences has a Current Valuation of 107.94 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is significantly lower than that of the firm.

Gilead Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gilead Sciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gilead Sciences could also be used in its relative valuation, which is a method of valuing Gilead Sciences by comparing valuation metrics of similar companies.
Gilead Sciences is currently under evaluation in current valuation category among related companies.

Gilead Sciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Gilead Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Gilead Sciences' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Gilead Fundamentals

About Gilead Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Gilead Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gilead Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gilead Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company was incorporated in 1987 and is headquartered in Foster City, California. Gilead Sciences operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 14400 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Gilead Sciences Piotroski F Score and Gilead Sciences Altman Z Score analysis.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.